Roche Holding AG
RHHBF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$399.21B
Close$
Earnings Call Q2 2024
July 25, 2024 - AI Summary
Group sales increased by 8% in the first half of the year, excluding COVID impact.
Pharma division saw strong growth in base business with an 8% increase in sales.
Diagnostics division also experienced solid growth with a 9% increase in sales.
Exclusive for Stockcircle Pro members
Sign up
$413.85
15.8% downside
Current Fair Value
15.8% downsideOvervalued by 15.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $399.21 Billion |
|---|---|
| Enterprise Value | $425.42 Billion |
| Annual dividend | $12.41 |
| Dividend yield | 2.43% |
| Earnings per Share | $16.19 |
| Beta | 0.38 |
| Outstanding Shares | 809,257,000 |
Return
| Return on Equity | 66.85% |
|---|---|
| Return on Assets | 22.26% |
| Return on Invested Capital | 42.92% |
Valuation & Multiples
| P/E Ratio | 26.26 |
|---|---|
| PEG | -336.92 |
| Price to Sales | 3.23 |
| Price to Book Ratio | 10.92 |
| Enterprise Value to Revenue | 3.45 |
| Enterprise Value to EBIT | 14.37 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.97 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$12.51
Consensus analyst estimateRevenue Estimate
$37.65 B
Consensus analyst estimateNext Earnings Call
Expected Date
January 28, 2027
EPS Estimate
$11.73
Consensus analyst estimateRevenue Estimate
$40.30 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Roche Holding AG
103,249 employees
CEO: Severin Schwan
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ...